Bioton

BIOTON S.A. is an innovation-driven biotechnology company. The company's main therapeutic area is diabetes. It provides recombinant human insulin for injectables and oral hypoglycemic agents, including glimepiride and metformin. Other over-the-counter pharmaceutical products, such as cardiovascular products, a range of supplements, nutritional products, and cosmetics, support the diabetes franchise in the Chinese market. For most people with diabetes, recombinant human insulin is an effective and safe therapy. Our goal is to become the preferred provider of comprehensive diabetes solutions for patients, doctors, and the diabetes community.